Skip to main content
Have a personal or library account? Click to login
Translation and Linguistic Validation of the Albanian Version of EORTC QLQ BN-20 Questionnaire Cover

Translation and Linguistic Validation of the Albanian Version of EORTC QLQ BN-20 Questionnaire

Open Access
|Sep 2026

References

  1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  2. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708
  3. Ostrom QT, Price M, Neff C, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019. Neuro Oncol. 2022;24(Suppl 5):v1–v95. doi:10.1093/neuonc/noac202
  4. International Agency for Research on Cancer. Population Fact Sheets 2020. Accessed December 10, 2023: https://gco.iarc.fr/today/data/factsheets/populations/8-albania-fact-sheets.pdf
  5. Randazzo D, Peters KB. Psychosocial distress and its effects on the health-related quality of life of primary brain tumor patients. CNS Oncol. 2016;5(4):241–249. doi:10.2217/cns-2016-0010
  6. Kirkbride P, Tannock IF. Trials in palliative treatment—have the goal posts been moved? Lancet Oncol. 2008;9(3):186–187. doi:10.1016/S1470-2045(08)70041-X
  7. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996. doi:10.1056/NEJMoa043330
  8. Taphoorn MJ, Bottomley A. Health-related quality of life and symptom research in glioblastoma multiforme patients. Expert Rev Pharmacoecon Outcomes Res. 2005;5(6):763–774. doi:10.1586/14737167.5.6.763. PMID: 19807618
  9. Cella D, Chang CH, Lai JS, Webster K. Advances in quality of life measurements in oncology patients. Semin Oncol. 2002;29(3 Suppl 8):60–68. doi:10.1053/sonc.2002.33535. PMID: 12082656
  10. Liu R, Page M, Solheim K, Fox S, Chang SM. Quality of life in adults with brain tumors: current knowledge and future directions. Neuro Oncol. 2009;11(3):330–339. doi:10.1215/15228517-2008-093
  11. Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002;57(1):41–49. doi:10.1023/a:1015728825642
  12. Liang SY, Liu HC, Lu YY, Wu SF, Chien CH, Tsay SL. The Influence of Resilience on the Coping Strategies in Patients with Primary Brain Tumors. Asian Nurs Res (Korean Soc Nurs Sci). 2020;14(1):50–55. doi:10.1016/j.anr.2020.01.005
  13. Zahid N, Khalid W, Ahmad K, et al. Resilience and quality of life (QoL) of head and neck cancer and brain tumour survivors in Pakistan: an analytical cross-sectional study protocol. BMJ Open. 2019;9(9):e029084. Published 2019 Sep 20. doi:10.1136/bmjopen-2019-029084
  14. Shahzad F, Khan M, Ahmed K, Zahid N, Rahman F. Reconstruction of Hemiglossectomy Defects With the Lateral Arm Fasciocutaneous Flap. J Craniofac Surg. 2021;32(8):e689–e693. doi:10.1097/SCS.0000000000007608
  15. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi:10.1093/jnci/85.5.365
  16. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–579. doi:10.1200/JCO.1993.11.3.570
  17. Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu MA, Yung WK, et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res. 1996;5(1):139–150. doi:10.1007/BF00435979
  18. Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, et al. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur J Cancer. 2010;46(6):1033–1040. doi:10.1016/j.ejca.2010.01.012
  19. Weitzner MA, et al. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer. 1995;75(5):1151–1161. doi:10.1002/1097-0142(19950301)75:5<;1151::aidcncr2820750515>3.0.co;2-q
  20. Shuleta-Qehaja S, et al. Evaluation of reliability and validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30, Albanian version) among breast cancer patients from Kosovo. Patient Prefer Adherence. 2015;9:459–465. doi:10.2147/PPA.S78334
  21. CONSTITUTION OF ALBANIA. (1998). In https://www.gjk.gov.al/web/constitution_of_albania_2090.pdf [Legal document].
  22. Dumani B, Nurja I, Subashi B, Dumani N. Regional inequality of economic and social developments in Albania. Acad J Interdiscip Stud. 2020;9(4):231. doi:10.36941/ajis-2020-0078
  23. Fayers P, Bottomley A; EORTC Quality of Life Group; Quality of Life Unit. Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer. 2002;38(Suppl 4):S125–S133. doi:10.1016/s0959-8049(01)00448-8
  24. Kuliś D, Bottomley A, Velikova G, Greimel E. On behalf of the EORTC Quality of Life Study Group. Translation Procedure. Fourth Edition. European Organisation for Research and Treatment of Cancer. Accessed 3 November, 2022: https://www.eortc.org/app/uploads/sites/2/2018/02/translation_manual_2017.pdf.
  25. THE ASSEMBLY. (2008). LAW No. 9887 dated 10.03.2008 ON PROTECTION OF PERSONAL DATA. In THE ASSEMBLY.
  26. Budrukkar A, Jalali R, Kamble R, Parab S. Translation and pilot validation of Hindi translation of assessing quality of life in patients with primary brain tumours using EORTC brain module (BN-20). J Cancer Res Ther. 2006;2(4):166–170. doi:10.4103/0973-1482.29826.
DOI: https://doi.org/10.2478/fco-2024-0031 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Submitted on: Mar 10, 2025
Accepted on: Dec 8, 2025
Published on: Sep 26, 2026
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services

© 2026 Mitilda Gugu, Armelda Teta, Elona Dybeli, Elona Gaxhja, Anastela Mano, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.